News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...
Pfizer Inc. (NYSE:PFE) is one of the Best Large Cap Value Stocks to Invest In. Morningstar reduced its moat rating for the ...
1d
Zacks.com on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.
Okay, well, I have not been recommending, my stock in the pharma business is Lilly, and the med equipment is Abbott. I do ...
Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...
But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...
13don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.
This was the stock's second consecutive day of losses.
6don MSN
Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results